Dr. Marc Siegel, Fox News’ senior medical analyst, discusses the latest discounted products available through President Donald Trump’s initiative on ‘The Bottom Line.’
EXCLUSIVE: FOX Business has learned that the White House is preparing to announce that more pharmaceutical companies will be offering discounted drugs on TrumpRx.gov.
Amgen and GSK are expected to join the list of drug manufacturers providing discounts on the government’s website as soon as today. This brings the total to 54 prescription medications from six pharmaceutical firms participating in the “most-favored-nation” pricing scheme, influenced by President Donald Trump’s pressure and tariff warnings.
Amgen plans to list a medication on the site at an 80% reduction from its retail cost. For example, Amjevita, originally priced at $1,484, will be sold for $299 on TrumpRx.gov. This drug is used to treat conditions such as rheumatoid arthritis, psoriasis, and ulcerative colitis.
FOX NEWS POLL: VOTERS SOUND ALARM ON HEALTHCARE COSTS
President Donald Trump addresses an audience while Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, observes during a drug pricing event at the South Court Auditorium on the White House campus in Washington, D.C., on February 5, 2026. (Nathan Howard/Getty Images)
Amgen also intends to offer Aimovig and Repatha at a 62% discount.
GSK will provide Incruse at 55% below its retail price. This medication for COPD will be available for $159.
Additionally, GSK plans to offer Arnuity, Relenza, and Anoro with price reductions between 10% and 51%.
| Ticker | Security | Last | Change | Change % |
|---|---|---|---|---|
| AMGN | AMGEN INC. | 366.21 | -1.58 | -0.43% |
| GSK | GSK PLC | 53.39 | -0.89 | -1.64% |
White House spokesman Kush Desai informed FOX Business that “GSK and Amgen’s participation with TrumpRx.gov, enabling them to provide prescription drugs directly to consumers at most-favored-nation pricing, represents another significant achievement for President Trump’s initiative to make healthcare more affordable.”
Desai added, “However, TrumpRx.gov is merely the start; Americans can anticipate even larger drug pricing discounts, reduced insurance premiums, and increased transparency once Congress approves President Trump’s Great Healthcare Plan.”
Amgen is set to provide medication through the website with an 80% reduction from its standard retail price. (George Frey/Bloomberg via Getty Images)
Major pharmaceutical companies are represented by the Pharmaceutical Research and Manufacturers of America (PhRMA).
Stephen Ubl, the CEO, stated his belief that “government-mandated most-favored-nation policies would diminish U.S. competitiveness and fail to resolve insurance practices that restrict access to care and increase patient expenses.”
HOUSE GOP SEEKS OFF-RAMP TO SKY-HIGH HEALTH INSURANCE COSTS FOR MILLIONS OF AMERICANS
He further argued, “Such policies would divert billions from American research and development, impede the discovery of new cures, and heighten dependence on China for future breakthroughs.”
GSK plans to offer Incruse at a 55% discount from its retail cost. (Jeffrey Greenberg/Universal Images Group via Getty Images)
As Americans continue to seek ways to lower healthcare expenses, the White House is proceeding with further announcements regarding TrumpRx.gov.
GET FOX BUSINESS ON THE GO BY CLICKING HERE
According to Bureau of Labor Statistics data, prescription drug costs rose by 10.4% between January 2021 and January 2025 during the Biden administration. In contrast, under the Trump administration, prescription drug prices saw a 0.2% increase from January 2025 through the most recent data available in February 2026.